Redefining precision.
Reimagining discovery.

We combine quantum physics, causal biology, multi-omics and native-AI to develop the next generation of novel therapeutics – with greater precision, faster, and always with patients in mind.

Based in Zurich. Built by experts from the worlds of pharma, business, finance, AI, and
bio-sciences. Backed by data. Driven by impact.

Who we are
What we do
Elixion’s R&D approach
Meet the team
Pipeline
Newsroom
Careers
Contact